Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs111713798 | chr1:150913257 | C/T | 4.32E-5 | 176 | 24.53 | 31.68 | 15 | KM Plot |
PCPG | rs111715087 | chr17:80500053 | T/TTG | 9.37E-7 | 174 | 25.92 | 22.42 | 8.75 | KM Plot |
PCPG | rs11171803 | chr12:56718422 | T/C | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs11171806 | chr12:56733531 | A/G | 9.51E-8 | 178 | 0.8 | 27.33 | 25.08 | KM Plot |
PCPG | rs111736578 | chr2:121545824 | G/A | 0.000214 | 177 | 25.53 | 24.37 | 59.77 | KM Plot |
PCPG | rs111778071 | chr3:53087119 | GA/G | 7.94E-6 | 173 | 25.08 | 27.27 | 11.78 | KM Plot |
PCPG | rs111786594 | chr14:74457093 | A/G | 3.3E-6 | 177 | 25.08 | 30.63 | 10.3 | KM Plot |
PCPG | rs111814267 | chr14:74493013 | T/G | 1.57E-6 | 177 | 25.17 | 28.47 | 4.5 | KM Plot |
PCPG | rs111828066 | chr3:195726869 | C/T | 1.24E-5 | 177 | 24.52 | 31.47 | 13.38 | KM Plot |
PCPG | rs111839189 | chr17:1410684 | T/C | 1.46E-5 | 174 | 25.05 | 25 | 25.17 | KM Plot |
PCPG | rs111843720 | chr7:158675232 | T/C | 0 | 177 | 25.53 | 20.37 | 3.17 | KM Plot |
PCPG | rs111844272 | chr9:86453553 | T/A | 0.000128 | 176 | 26.22 | 24.7 | 14.47 | KM Plot |
PCPG | rs111853690 | chr13:114169933 | A/G | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs111871204 | chr9:86440448 | T/C | 0.000131 | 175 | 26.22 | 24.93 | 14.47 | KM Plot |
PCPG | rs111872568 | chr14:74302663 | G/C | 4.55E-6 | 174 | 25.47 | 27.75 | 10.43 | KM Plot |